Genetic and Chemical Screening in Human Blood Serum Reveals Unique Antibacterial Targets and Compounds against Klebsiella pneumoniae.

Cell Reports
Brent S WeberEric D Brown

Abstract

Antibiotics halt the growth of bacteria by targeting core, essential physiology that is required for life on standard microbiological media. Many more biochemical and virulence processes, however, are required for bacteria to cause infection in a host. Indeed, chemical inhibitors of the latter processes are overlooked using conventional antibiotic drug discovery approaches. Here, we use human blood serum as an alternative growth medium to explore new targets and compounds. High-throughput screening of genetic and chemical libraries identified compounds targeting biological activities required by Klebsiella pneumoniae to grow in serum, such as nucleobase biosynthesis and iron acquisition, and showed that serum can chemically transform compounds to reveal cryptic antibacterial activity. One of these compounds, ruthenium red, was effective in a rat bloodstream infection model. Our data demonstrate that human serum is an effective tool to find new chemical matter to address the current antibiotic resistance crisis.

References

Jul 1, 1975·Antimicrobial Agents and Chemotherapy·I Jit Sud, D S Feingold
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·H Pruul, P J McDonald
Sep 21, 1990·European Journal of Pharmacology·R AmannF Lembeck
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jan 1, 1987·Pharmacology & Therapeutics·F M Williams
Nov 1, 1986·The Journal of Antimicrobial Chemotherapy·J M Diver, R Wise
Jan 22, 1971·Biochemical and Biophysical Research Communications·C L Moore
Nov 11, 1999·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·T A Fassel, C E Edmiston
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Jun 1, 1992·Applied and Environmental Microbiology·J M KlinglerD L Pierson
Mar 25, 2004·The Journal of Biological Chemistry·Manas Kumar SantraDulal Panda
Oct 15, 1958·Proceedings of the National Academy of Sciences of the United States of America·S S CohenJ Lichtenstein
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Terence I MoyFrederick M Ausubel
Apr 1, 1981·Biophysical Chemistry·R L KarpelS R Holt
Feb 20, 2008·PLoS Pathogens·Shalaka SamantAlexander A Neyfakh
Mar 14, 2009·Journal of Industrial Microbiology & Biotechnology·Ronald Bentley
Aug 25, 2009·The American Journal of Medicine·Bonnie L MeatherallKevin B Laupland
Aug 29, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Abraham BorerMichael Sherf
Oct 15, 2009·Genome Research·Gemma C LangridgeA Keith Turner
Feb 2, 2011·Mayo Clinic Proceedings·Surbhi LeekhaRandall S Edson
Jan 1, 2010·International Journal of Tryptophan Research : IJTR·S ComaiC V L Costa
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julien M BuyckFrançoise Van Bambeke
Aug 24, 2012·Science Translational Medicine·Evan S SnitkinJulia A Segre
Oct 15, 2013·Nature Chemical Biology·Soumaya ZlitniEric D Brown
May 16, 2014·Journal of Biomolecular Screening·Chand S MangatEric D Brown
Dec 30, 2014·Chemistry & Biology·Vinayak SinghValerie Mizrahi
Mar 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Keith H TurnerMarvin Whiteley
Apr 29, 2015·Frontiers in Microbiology·Adrián Rangel-VegaRodolfo García-Contreras
Jan 23, 2016·Nature·Eric D Brown, Gerard D Wright
Jan 23, 2016·Molecular Biology of the Cell·Shawn FrenchEric D Brown
Jun 16, 2016·MSphere·Sargurunathan SubashchandraboseHarry L T Mobley
Jul 2, 2016·Immunobiology·Dennis J DoorduijnBart W Bardoel
Sep 13, 2016·Annual Review of Genetics·Lauren D Palmer, Eric P Skaar

❮ Previous
Next ❯

Citations

Feb 10, 2021·Infection and Immunity·Shekina Gonzalez-FerrerDaria Van Tyne
Mar 12, 2021·Clinical Microbiology Reviews·Caitlyn L HolmesMichael A Bachman
Apr 1, 2021·Accounts of Chemical Research·Maya A FarhaEric D Brown
Jul 4, 2021·Nature Protocols·Corrie R Belanger, Robert E W Hancock

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.